June 11, 2018 – For Sandy Clark, the 340B program is personal. She was inspired to become a 340B coordinator due to the experience of one special patient in particular – her own son. Sandy’s son was diagnosed with Hodgkin’s lymphoma in 2005, just a month before graduating from high school. At the time, Meadville Medical Center in northwestern Pennsylvania did not have the … [Read more...]
Faces of 340B: “We Stand in that Gap”
May 24, 2018 – For Chuck Beams, it was one patient in particular who made him realize just how crucial the 340B program is to uninsured and underinsured patients with serious medical conditions. The patient from Auburn, Ala., required tens of thousands of dollars in infusions and other costly care for his cancer and had no idea how he was going to obtain the treatments until he … [Read more...]
What Does President Trump’s Drug Pricing Plan Mean for 340B?
May 11, 2018—While the 340B drug pricing program played a minor supporting role in President Trump’s drug pricing announcements today, it is certain to engender significant debate in the months ahead. The announcements made today no new policy proposals but did continue rhetorical attacks on the program. The President never uttered the words “340B” but did reference the … [Read more...]
PhRMA-Funded Study Contradicts Its Conclusions
March 19, 2018 – A new PhRMA-funded study released by Milliman suggests that 340B hospitals have higher drug spending for commercially insured patients than non-340B hospitals and claims that it is the result of inappropriate drug use. However, methodological flaws in the study raise serious questions about the findings. In fact, Milliman’s report includes data that indicate … [Read more...]
In Court Papers, 340B Hospitals Tell How Massive CMS Cuts Are Causing Irreparable Injury
March 1, 2018— Steep federal drug reimbursement cuts to hospitals in the 340B drug discount program are causing “irreparable injury…by jeopardizing essential programs and services provided to their communities and the vulnerable, poor and other underserved populations, such as oncology, dialysis, and immediate stroke treatment services,” three national hospital groups and three … [Read more...]
Rising Drug Prices Expected to Drive Healthcare Spending in Coming Decade
Feb. 15, 2018 – Rising drug prices will be a major driver of higher U.S. healthcare spending in the coming decade, new healthcare sending projections from the Centers for Medicare & Medicaid Services show. According to CMS’s annual projection, healthcare spending will grow an average of 5.5 percent a year from 2017 through 2026, led by prescription drug spending growth … [Read more...]
Is Trump Budget DOA? What About 340B Changes?
Feb. 13, 2018—Washington, D.C., has many traditions. Cherry blossoms in Spring. Oppressive heat and humidity in Summer. School closings due to snow flurries in Winter. This week marked the latest installment of another: the release of the President’s budget blueprint for the coming year. On Monday, President Trump released what the White House has dubbed “An American Budget” … [Read more...]